Vor Biopharma Inc.
USD18.60
+2.50 (+15.53%)
CEO
Jean-Paul Kress
IPO Date
2021-02-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$16.10
Prev. Close
$16.10
Day Low
$16.10
Day High
$18.76
52W Low
$6.50
52W High
$65.80
Market Cap
$0.13B
Volume
2.79M
| -0.7 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -78.2% | -56.2% | 0.24 | 9.04 | -1.3 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -36.7% | -30.8% | 0.16 | 18.06 | -2.9 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -31.9% | -28.4% | 0.08 | 21.12 | -6.3 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -89.8% | -57.1% | 0.38 | 4.81 | -32.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -141.9% | -110.3% | 0.00 | 3.45 | -128.4 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 61.4% | -412.3% | -0.66 | 0.12 | -51.1 |
| 0.0 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | 36.5% | -461.1% | -0.00 | 9.16 | -0.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 104.5% | -766.3% | 0.00 | 3.49 | -0.0 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -49.2% | -29.7% | 0.47 | 3.88 | -0.7 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -31.8% | -21.5% | 0.33 | 5.19 | -0.6 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -37.8% | -23.8% | 0.45 | 4.69 | -0.4 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -28.4% | -19.7% | 0.34 | 6.54 | -0.6 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -25.0% | -18.4% | 0.28 | 8.46 | -1.2 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -17.4% | -12.5% | 0.24 | 9.04 | -1.5 |